PV Bulletin

Dental Composite Resin Devices - Premarket Notification (510(k)) Submissions Guidance

The FDA has issued new guidance for the premarket notification submissions regarding dental composite resin devices.

Primary source: Download the Final Guidance Document

PV Impact Brief

Urgency: HighConfidence: high

What changed

The FDA has released a final guidance document on September 2, 2026, outlining comprehensive recommendations for device description, non-clinical and clinical performance testing, and labeling for dental composite resin devices.

Why it matters

This guidance is critical for manufacturers of dental composite resin devices as it establishes the standards and expectations for regulatory submissions, impacting compliance and market access.

Action needed

Companies preparing 510(k) submissions for dental composite resin devices must align with the recommendations specified in the new guidance, which include detailed testing and labeling criteria.

Relevant for
Regulatory Intelligence Lead
Processes impacted
Inspection Readiness
Owner

Regulatory Intelligence Lead

Review cadence

Review in the next regulatory intelligence cycle.

Evidence and confidence

Confidence: highSource updated: Sep 1, 2026

Full briefing

Practical implication

Companies preparing 510(k) submissions for dental composite resin devices must align with the recommendations specified in the new guidance, which include detailed testing and labeling criteria.

The FDA's updated guidance assists industry in preparing premarket notification submissions (510(k)s) for dental composite resin devices, reflecting current review practices and aiming to facilitate consistent submission reviews.

What changed: The FDA has released a final guidance document on September 2, 2026, outlining comprehensive recommendations for device description, non-clinical and clinical performance testing, and labeling for dental composite resin devices.

Why it matters: This guidance is critical for manufacturers of dental composite resin devices as it establishes the standards and expectations for regulatory submissions, impacting compliance and market access.

Practical implication: Companies preparing 510(k) submissions for dental composite resin devices must align with the recommendations specified in the new guidance, which include detailed testing and labeling criteria.

View original source

  • Source: FDA - Regulatory Information
  • Published at source: 2026-09-01T00:00:00.000Z
  • Discovered by monitor: 2026-09-01T22:08:08.426Z

Published from the regulator source ingestion pipeline after PV impact triage.

Related updates for your role

publicFDA · USA · Updated Sep 4, 2026

FDA Grants Accelerated Approval to Etcamah for Advanced Breast Cancer

Urgency: High

Regulatory teams must prepare for updating labeling to include details on the new indication and required diagnostic methods, along with planning for the confirmatory studies mandated by the FDA.

Signal ManagementLabelingRegulatory Intelligence Lead
SOP Impact2 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicMHRA · UK · Updated Sep 4, 2026

Change to the definition of regulated activity with children from 1 September 2026

Urgency: High

Organizations must re-evaluate roles related to children's activities and prepare to request Enhanced DBS checks including access to the Children’s Barred List check starting from 1 September 2026.

Country ComplianceRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicANSM (France) · France · Updated Sep 7, 2026Translated From French

Urgent Withdrawal of Reusable da Vinci S and Si Instruments Due to Cable Degradation

Urgency: High

Healthcare facilities must isolate the affected instruments and notify Intuitive Surgical for returns while preparing for potential delays in surgical procedures due to instrument replacements.

Signal ManagementRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Latest
Read impact briefarrow_forward
publicANSM · France · Updated Sep 7, 2026Translated From French

Injunction No. 2026-DM-031-INJ Regarding Ortho Partner Establishment in Montreuil

Urgency: High

Establish compliant storage conditions for medical devices and set up a non-conformity management system within 3 months.

Inspection ReadinessRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward